About Fidelity Disruptive Medicine ETF (FMED)

The Fidelity Disruptive Medicine ETF (FMED) is an innovative exchange-traded fund that focuses on disruptive technologies in the field of medicine. This ETF seeks to provide investors with exposure to companies that are at the forefront of medical advancements and are revolutionizing the healthcare industry. FMED offers a unique opportunity for investors to invest in companies that are driving significant changes in the way healthcare is delivered, improving patient outcomes, and reducing costs.

With a market cap of $X billion, FMED is a sizable ETF that has gained significant attention from investors. The fund aims to provide long-term capital appreciation by investing in companies that are revolutionizing various aspects of medicine, including telemedicine, genomics, biotechnology, and digital health. FMED's portfolio consists of companies that are disrupting traditional healthcare models and offering innovative solutions to address the challenges faced by the industry.